Dynamic regulation of estrogen receptor-beta expression by DNA methylation during prostate cancer development and metastasis.

[1]  S. Ho,et al.  PMP24, a gene identified by MSRF, undergoes DNA hypermethylation-associated gene silencing during cancer progression in an LNCaP model , 2004, Oncogene.

[2]  E. Lam,et al.  Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation. , 2003, Oncogene.

[3]  David C. Jones,et al.  The selective estrogen receptor modulator trioxifene (LY133314) inhibits metastasis and extends survival in the PAIII rat prostatic carcinoma model. , 2003, Cancer research.

[4]  Karen S Lavery,et al.  Antisense and RNAi: powerful tools in drug target discovery and validation. , 2003, Current opinion in drug discovery & development.

[5]  J. Gustafsson,et al.  Disruption of the estrogen receptor β gene in mice causes myeloproliferative disease resembling chronic myeloid leukemia with lymphoid blast crisis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[6]  A. Stephens,et al.  Antisense oligonucleotide therapy in cancer. , 2003, Current opinion in molecular therapeutics.

[7]  J. Groopman,et al.  DNA Methylation as a Cancer‐Specific Biomarker , 2003 .

[8]  A. Hoffman,et al.  A methylated oligonucleotide inhibits IGF2 expression and enhances survival in a model of hepatocellular carcinoma. , 2003, The Journal of clinical investigation.

[9]  J. Groopman,et al.  DNA methylation as a cancer-specific biomarker: from molecules to populations. , 2003, Annals of the New York Academy of Sciences.

[10]  Seong-Jin Kim,et al.  Raloxifene, a Mixed Estrogen Agonist/Antagonist, Induces Apoptosis through Cleavage of BAD in TSU-PR1 Human Cancer Cells* , 2002, The Journal of Biological Chemistry.

[11]  M. Turker.  Gene silencing in mammalian cells and the spread of DNA methylation , 2002, Oncogene.

[12]  J. Gustafsson,et al.  Estrogen receptor beta in the prostate , 2002, Molecular and Cellular Endocrinology.

[13]  G. Patrinos,et al.  DNA hypermethylation: when tumour suppressor genes go silent , 2002, Human Genetics.

[14]  S. Clark,et al.  DNA methylation analysis in mammalian cells. , 2002, Methods.

[15]  Y. Leung,et al.  Induction of UDP-glucuronosyltransferase 1A8 mRNA by 3-methylcholanthene in rat hepatoma cells. , 2002, Biochemical pharmacology.

[16]  R. Dahiya,et al.  CpG hypermethylation of the promoter region inactivates the estrogen receptor‐β gene in patients with prostate carcinoma , 2001, Cancer.

[17]  J. Gustafsson,et al.  Frequent Loss of Estrogen Receptor-β Expression in Prostate Cancer , 2001 .

[18]  I. Leav,et al.  Comparative Studies of the Estrogen Receptors β and α and the Androgen Receptor in Normal Human Prostate Glands, Dysplasia, and in Primary and Metastatic Carcinoma , 2001 .

[19]  M. Loda,et al.  Estrogen Receptor in Prostate Cancer , 2001 .

[20]  J. Kato,et al.  The multiple untranslated first exons system of the human estrogen receptor beta (ERβ) gene , 2001, The Journal of Steroid Biochemistry and Molecular Biology.

[21]  J. Herman,et al.  DNA methylation, chromatin inheritance, and cancer , 2001, Oncogene.

[22]  L. Andersson,et al.  A role for estrogen receptor β in the regulation of growth of the ventral prostate , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[23]  I. Leav,et al.  Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma. , 2001, The American journal of pathology.

[24]  J. Gustafsson,et al.  Frequent loss of estrogen receptor-beta expression in prostate cancer. , 2001, Cancer research.

[25]  J. Gustafsson,et al.  Role of estrogen receptor beta in estrogen action. , 2001, Annual review of physiology.

[26]  M. Loda,et al.  Estrogen receptor beta in prostate cancer: brake pedal or accelerator? , 2001, The American journal of pathology.

[27]  M. Bosland.  The role of steroid hormones in prostate carcinogenesis. , 2000, Journal of the National Cancer Institute. Monographs.

[28]  S. Ho,et al.  Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation. , 2000, Cancer research.

[29]  R. Dahiya,et al.  Cloning and characterization of human estrogen receptor beta promoter. , 2000, Biochemical and biophysical research communications.

[30]  A. Bird,et al.  Methylation-Induced Repression— Belts, Braces, and Chromatin , 1999, Cell.

[31]  B M Turner,et al.  Histone deacetylases: complex transducers of nuclear signals. , 1999, Seminars in cell & developmental biology.

[32]  J. Lehmann,et al.  Cloning and Characterization of Human Estrogen Receptor β Isoforms , 1998 .

[33]  J. Lehmann,et al.  Cloning and characterization of human estrogen receptor beta isoforms. , 1998, Biochemical and biophysical research communications.

[34]  B. Katzenellenbogen,et al.  The quinone reductase gene: a unique estrogen receptor-regulated gene that is activated by antiestrogens. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Polman,et al.  ERβ: Identification and characterization of a novel human estrogen receptor , 1996 .

[36]  J. Gustafsson,et al.  Cloning of a novel receptor expressed in rat prostate and ovary. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Polman,et al.  ER beta: identification and characterization of a novel human estrogen receptor. , 1996, FEBS letters.

[38]  J. Cuzick.  A Wilcoxon-type test for trend. , 1985, Statistics in medicine.

[39]  G. N. Lance,et al.  A General Theory of Classificatory Sorting Strategies: 1. Hierarchical Systems , 1967, Comput. J..